Evidence map›Paper›PMID 16630952›Full record

ArticleThe Journal of allergy and clinical immunology2006

Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis.

Paulo R Z Antas, Li Ding, Judith Hackman, Linda Reeves-Hammock, Ayumi K Shintani, Joshua Schiffer, Steven M Holland, Timothy R Sterling

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Abnormal spontaneous interleukin 8 receptor expression: a brief report of two cases.Revista da Sociedade Brasileira de Medicina Tropical · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Paulo R Z AntasDivision of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2605, USA.
Li Ding
Judith Hackman
Linda Reeves-Hammock
Ayumi K Shintani
Joshua Schiffer
Steven M Holland
Timothy R Sterling
National Institutes of Health · USOffice of Infectious Diseases · USBaltimore City Health Department · USJohns Hopkins University · USMetro Health Hospital · USVanderbilt University Medical Center · US

Funding

ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
Genes And Gene Products As ImmunoadjuvantsZIAAI000647 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOLLAND, STEVEN · 2009 to 2025
$22.6M
GENES AND GENE PRODUCTS AS IMMUNOADJUVANTSZ01AI000647 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HOLLAND, STEVEN M · 1992 to 2008
$5.4M
RISK FACTORS FOR EXTRAPULMONARY TUBERCULOSISK23AI001654 · NIAID · VANDERBILT UNIVERSITY · PI STERLING, TIMOTHY R · 2000 to 2004
$653k
NCRR NIH HHS M01-RR00052NIAID NIH HHS K23-AI01654
6 · The paper itself

Abstract

backgroundCD4+ lymphocytes control Mycobacterium tuberculosis infection through cytokine-mediated macrophage activation. Extrapulmonary tuberculosis is presumably a marker of immunodeficiency, but cytokine responses have not been well studied in such patients.

objectiveAssess immune defects in persons with previous extrapulmonary tuberculosis.

methodsIn vitro cytokine responses of PBMCs from HIV-seronegative adults with previous extrapulmonary tuberculosis (n = 10) were compared with responses from persons with previous pulmonary tuberculosis (n = 24) and latent M tuberculosis infection (n = 30) in a case-control study.

resultsPatients and controls did not differ according to age, sex, race, or monocytes. The median time between tuberculosis diagnosis and study entry was 72 and 122 weeks in extrapulmonary and pulmonary patients, respectively (P = .2). Median CD4+ counts were 660, 814, and 974 lymphocytes/mm3 in extrapulmonary, pulmonary, and latently infected patients, respectively (P = .03). At 48 hours, median unstimulated cytokine levels were uniformly lower in extrapulmonary patients than both sets of controls. These differences persisted after controlling for CD4+ count by linear regression analysis. Despite lower unstimulated levels, median TNF-alpha response was higher in patients with extrapulmonary and pulmonary tuberculosis than latently infected persons after stimulation with PHA 1% (P = .006) and PHA+IL-12 (1 ng/mL; P = .02); IL-10 remained low in patients with extrapulmonary tuberculosis after the same stimuli (P = .04 and .06, respectively). There was no primary immunodeficiency in the IL-12/23-IFN-gamma axis.

conclusionHIV-seronegative adults with previous extrapulmonary tuberculosis had lower CD4+ lymphocytes and unstimulated cytokine production. This suggests a subtle abnormality in innate immune function. CLINICAL IMPLICATIONS: These characteristics could identify persons at risk for severe tuberculosis manifestations.

Indexed as

CD4 Lymphocyte CountImmunity, InnateAdultCytokinesFemaleHumansIn Vitro TechniquesLeukocytes, MononuclearMaleMiddle AgedTuberculosisTuberculosis, PulmonaryCytokines

Identifiers

PMID16630952
OpenAlexW2154817504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.